Advertisement
 1  2  3  4  
  • Basic Info
Licensed from
Generic: Guggul
treats Obesity, Rheumatoid arthritis, Osteoarthritis, Acne, and Hypercholesterolemia
               



To get info about second drug, type a name above.


Tradition

WARNING: DISCLAIMER: The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below.
Asthma, bleeding, colitis, diabetes, gingivitis, hemorrhoids, leprosy, leucorrhoea, menstrual disorders, mouth infections, neuralgia, obesity, pain, psoriasis, rhinitis, sores, sore throat, tumors, weight loss, wound healing.

Dosing

Adults (18 years and older):

There is no proven effective dose for guggul in adults. For hyperlipidemia, 500- 1,000 milligrams of guggulipid (standardized to 2.5% guggulsterones) taken 2- 3 times daily has been used. An equivalent dose of commercially prepared guggulsterone is 25 milligrams three times daily or 50 milligrams twice daily by mouth. A higher dose has been studied (2,000 milligrams three times daily, standardized to 2.5% guggulsterones), although this dose may be associated with a greater risk of hypersensitivity skin reactions. For nodulocystic acne, dose of guggulipid equivalent to 25 milligrams guggulsterone per day has been used.

Children (younger than 18 years):

There is no proven effective dose for guggul in children.

Safety

DISCLAIMER: Many complementary techniques are practiced by healthcare professionals with formal training, in accordance with the standards of national organizations. However, this is not universally the case, and adverse effects are possible. Due to limited research, in some cases only limited safety information is available.

Allergies:

Avoid in individuals with a known allergy or hypersensitivity to guggul or any of its constituents. Hypersensitivity skin reactions have been noted, in most cases within 48 hours of starting therapy, and resolving spontaneously within one week of therapy discontinuation.

Side Effects and Warnings:

Standardized gugulipid is generally regarded as safe in healthy adults at recommended doses for up to six months. Gastrointestinal upset is the most common adverse effect, as well as diarrhea, nausea, vomiting, burping, and hiccough. Headache, restlessness, and anxiety have been noted in studies. Allergic skin rash (especially at higher doses) has been reported.

Gugulipid has been associated with inhibition of platelets and increased fibrinolysis (blood clot breakdown), and in theory the risk of bleeding may increase.

Although not well studied in humans, weight loss and stimulation of thyroid function may occur.

Pregnancy and Breastfeeding:

Guggul is not recommended in pregnant or breastfeeding women due to a lack of available scientific evidence.

               
 1  2  3  4  
               
Advertisement